Geneva, October 3, 2017
Released jointly by WIPO & IFPMA
The Globe Intellectual Property Organization (WIPO) & the research-based pharmaceutical industry today launched a new partnership to promote the accessibility of patent information for health agencies tasked with procurement of medicines.
WIPO Director General Francis Gurry and Mr. Thomas Cueni, Director General of the Global Federation of Pharmaceutical Manufacturers and Associations (IFPMA), signed an agreement establishing the Patent Information Initiative for Medicines, or âPat-INFORMED,â on the sidelines of the Assemblies of the Member States of WIPO.
WIPO & IFPMA, the intercontinental trade association representing the research-based pharmaceutical industry, are co-sponsors of the initiative, which originated in the industryâs efforts to add clarity to the patent information around medicines. It couples the industryâs work in this area with WIPOâs well-established expertise in organizing patent data from across the world.
Pat-INFORMED will clearly link public patent information to registered medicines in a new online world gateway, helping health professionals to navigate the medicine-procurement process for the benefit of their citizens.Â
âPat-INFORMED will make it easier for procurement experts to assess the patent status of medicines, underlining how a well-designed & implemented patent system incentivizes innovation while making available & accessible key information about patented inventions,â said Mr. Gurry. âI welcome the engagement of IFPMA and its membership in this initiative, which responds to real needs in the public health community.â
âWe can proudly say that this collaboration with WIPO shows the private sectorâs initiative to propose practical solutions to reduce the complexity around patent information.Â Helping ease access to patent information for public health authorities can help them establish smarter procurement strategies, one building block of improved global health,â said Mr. Thomas Cueni, Director General IFPMA.
Pat-INFORMED will act as a global gateway to medicine patent information.Â It will offer new tools & resources to determine the existence of patents relevant to products sought by procurement bodiesâ disease-management strategies or other work addressing public health needs.
Twenty leading international research-based biopharmaceutical companies have already committed to make information available via a database to be established by Pat-INFORMED, with more organizations expected to join.
âThe Pat-INFORMED initiative launched today by IFPMA & WIPO is an important step to reduce uncertainty and improve transparency in medicines procurement. By adding the information on the intercontinental patent status from patent-holding companies to that from national patent offices, the process for procurement agencies & other people to determine the scope of patent protection for medicines will be markedly improved. I am delighted that the pharmaceutical industry has taken this important step,â said Mr. Trevor Mundel, President of the Intercontinental Health Division at the Gates Foundation.
While patent information is publicly available around the international, resources that directly link granted patents to marketed medicines are currently only available publicly in certain countries (e.g. the USAâs âOrange Bookâ) or through private third-party databases.Â
Pat-INFORMED aims to help close these gaps, and make the management of patent issues in procurement less time- & resource-intensive. Pat-INFORMED also offers qualified procurement agencies a communication channel for follow-on inquiries, through which participating companies have agreed to provide more detailed information about granted patents on specific products.
The online initiative is expected to be operational by mid-2018 & will provide patent information for small molecule products within oncology; hepatitis C, cardiovascular, HIV, diabetes, & respiratory therapy areas; & any products on the WHO Essential Medicines List that are not within these therapy areas. In a second phase, the initiative will expand to all therapeutic areas & explore the inclusion of complex therapeutics.Â
IFPMA represents research-based pharmaceutical companies & associations across the globe. The research-based pharmaceutical industry’s two million employees discover, develop, & deliver medicines & vaccines that improve the lives of patients intercontinental. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the world health community find solutions that improve global health.Â
For further information, please contact Sadia Kaenzig, Communications Manager at IFPMA
The International Intellectual Property Organization (WIPO) is the intercontinental forum for intellectual property policy, services, information & cooperation. A specialized agency of the United Nations, WIPO assists its 191 member states in developing a balanced world IP legal framework to meet society’s evolving needs. It provides business services for obtaining IP rights in multiple countries & resolving disputes. It delivers capacity-building programs to help developing countries benefit from using IP. & it provides free access to unique knowledge banks of IP information.
For further information, please contact the Media Relations Section at WIPO:
- Tel: (+41 22) 338 81 61 / 338 72 24
- Fax: (+41 22) 338 81 40